Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC. (Q38956735)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 October 2014

Language	Label	Description	Also known as
English	Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.	scientific article published on 21 October 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

Yu-Yang Pang

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ting Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Fang-Yuan Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ying-Li Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Xia Shao

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Fei Xiao

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Hong-Hui Huang

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Hua Zhong

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ji-Hua Zhong

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1821-1830

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

MYC on the path to cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

2-Deoxy-D-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKβ leading to autophagy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Pyrvinium targets autophagy addiction to promote cancer cell death

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.963575

21 January 2018

Identifiers

10.3109/10428194.2014.963575

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38956735&oldid=1765505924"